Read perspectives from The Cancer Genome Atlas’ (TCGA) stakeholders on issues that are important to TCGA and the cancer genomics community.
TCGA and Its Vital Role in Understanding How Germline Variation Informs the Landscape of Somatic Alterations in Cancer
Dr. Stephen Chanock, M.D., Director of the Division of Cancer Epidemiology & Genetics at the NCI, discusses how TCGA provides as a strong foundation for understanding key biological alterations in cancer.
The New Backbone of Clinical Trial Design
Dr. Douglas Levine, Head of the Gynecology Research Laboratory at Memorial Sloan-Kettering Cancer Center, writes about genomics directed trials in gynecological cancers.
TCGA Data and Cancer Systems Biology: Ex pluribus unum
Dr. Andrea Califano, Ph.D., founding director of the Columbia Initiative in Systems Biology at Columbia University in New York, shares his Perspective on the impact of TCGA.
Dealing with Chaos
Dr. George Sledge, American Society of Clinical Oncology President, speaks about what he learned at the most recent TCGA Steering Committee Meeting.
TCGA Expands Research Horizons
Rajiv Dhir, M.D. shares his Perspective on the partnership between TCGA and the University of Pittsburgh.
The Power of Volunteerism
The Dr. Susan Love Research Foundation, joined forces with the Avon Foundation for Women to launch the Army of Women, an initiative to recruit 1 million women to participate in breast cancer research. Susan Love, M.D., shares her Perspective on the power of volunteerism.